Saturday
19 September
08:30 – 09:30 Discussion planning results from day 1
All
09:30 – 10:00 Relationships between 3D dose distributions and
clinical toxicities – H&N and Pelvis
N. Dinapoli
10:00 – 10:15 Rationale behind IMRT
M. Sharpe
10:15 – 10:45
Coffee break
10:45 – 11:15 Concepts in inverse planning
M. Sharpe
11:15 – 12:05 Practical aspects of IMRT planning (Part 1)
G. Meijer
12:05 – 12:40 Practical aspects of IMRT planning (Part 2)
M. Stock
12:40 – 13:40
Lunch
13:40 – 14:10
Company presentation
14:10 – 14:30 Physical and biological optimisation
G. Meijer
14:30 – 14:45 Introduction Case 2: prostate
D. van den
Bongard
14:45 – 14:55 Planning aspects case 2
G. Meijer
14:55 – 16:25 Individual planning (non-IMRT)
16:25 – 16:40
Coffee break
16:40 – 18:00 Individual planning (non-IMRT)
All




